Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Novel Phenotypic Fluorescent Three-Dimensional Platforms For High-throughput Drug Screening And Personalized Chemotherapy

Changge Fang, I. Avis, D. Salomon, F. Cuttitta
Published 2013 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
We have developed novel phenotypic fluorescent three-dimensional co-culture platforms that efficiently and economically screen anti-angiogenic/anti-metastatic drugs on a high-throughput scale. Individual cell populations can be identified and isolated for protein/gene expression profiling studies and cellular movement/interactions can be tracked by time-lapse cinematography. More importantly, these platforms closely parallel the in vivo angiogenic and metastatic outcomes of a given tumor xenograft in the nude mouse model but, unlike in vivo models, our co-culture platforms produce comparable results in five to nine days. Potentially, by incorporating cancer patient biopsies, the co-culture platforms should greatly improve the effectiveness and efficiency of personalized chemotherapy.
This paper references
Angiogenesis by capillary endothelial cells in culture.
J. Folkman (1980)
10.1016/S0140-6736(96)91015-6
The war on cancer
M. Sporn (1996)
The role of angiogenesis in tumor growth.
J. Folkman (1992)
Antiangiogenesis in cancer therapyand its mechanisms of action
J Folkman (2006)
10.1126/SCIENCE.1064829
Taking Cell-Matrix Adhesions to the Third Dimension
E. Cukierman (2001)
[Inflammation and cancer].
I. M. Neiman (1974)
10.1016/S0092-8674(00)80108-7
Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis
D. Hanahan (1996)
Angiogenesis. J Biol Chem
J Folkman (1992)
10.1038/427787a
Cancer without disease
J. Folkman (2004)
10.1038/35094059
Putting tumours in context
M. Bissell (2001)
10.1038/nprot.2008.226
Spheroid-based drug screen: considerations and practical approach
J. Friedrich (2009)
10.1093/HMG/DDS317
Exosomes and microvesicles: extracellular vesicles for genetic information transfer and gene therapy.
Yi Lee (2012)
10.1016/J.YGYNO.2005.05.042
Mast cell density, angiogenesis, blood clotting, and prognosis in women with advanced ovarian cancer.
J. Chan (2005)
10.1093/JNCI/82.1.4
What is the evidence that tumors are angiogenesis dependent?
J. Folkman (1990)
10.1002/IJC.2910180520
Mast cells and tumor angiogenesis
D. A. Kessler (1976)
10.1073/PNAS.76.10.5217
Long-term culture of capillary endothelial cells.
J. Folkman (1979)
10.1159/000047855
Pericytes: Cell Biology and Pathology
G. Allt (2001)
10.1210/en.2011-1667
Angiogenic deficiency and adipose tissue dysfunction are associated with macrophage malfunction in SIRT1-/- mice.
F. Xu (2012)
10.1016/j.leukres.2009.02.028
Mast cells and angiogenesis in haematological malignancies.
D. Ribatti (2009)
10.1080/00313020412331282708
Angiotropic malignant melanoma and extravascular migratory metastasis: description of 36 cases with emphasis on a new mechanism of tumour spread
R. Barnhill (2004)
Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors.
K. Samoto (1995)
10.1290/0604027.1
Life ins't flat: Taking cancer biology to the next dimension
K. Smalley (2007)
10.1016/S0959-8049(96)00401-7
Transgenic mouse models of tumour angiogenesis: the angiogenic switch, its molecular controls, and prospects for preclinical therapeutic models.
D. Hanahan (1996)
10.1038/424870a
Cell culture: Biology's new dimension
A. Abbott (2003)
10.1084/JEM.136.2.261
TUMOR DORMANCY IN VIVO BY PREVENTION OF NEOVASCULARIZATION
M. Gimbrone (1972)
10.1056/NEJM197111182852108
Tumor angiogenesis: therapeutic implications.
J. Folkman (1971)
10.1126/science.560061
Primary bioassay of human tumor stem cells.
A. Hamburger (1977)
10.1021/mp800047v
3-D tumor model for in vitro evaluation of anticancer drugs.
Jayme L Horning (2008)
Angiogenesis: an organizing principle for drug discovery?
J. Folkman (2007)
10.1155/2012/362784
Thigmotropism of Malignant Melanoma Cells
P. Quatresooz (2012)
10.1016/j.cell.2007.01.021
Chemical Genetics: Where Genetics and Pharmacology Meet
Z. Knight (2007)
10.1016/j.ejca.2010.02.039
Cancer metastasis as a therapeutic target.
J. Sleeman (2010)
10.1093/JNCI/DJI011
Role of human cripto-1 in tumor angiogenesis.
C. Bianco (2005)
10.1186/bcr86
Molecular biology of breast cancer metastasis: Clinical implications of experimental studies on metastatic inefficiency
A. Chambers (2000)
10.1016/j.bbadis.2010.11.010
Mast cells, angiogenesis, and tumour growth.
D. Ribatti (2012)
10.1016/S0002-9440(10)64400-8
Angiogenesis and vascular architecture in pheochromocytomas: distinctive traits in malignant tumors.
J. Favier (2002)
10.1172/JCI17929
Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors.
G. Bergers (2003)
10.3171/SPI.2007.6.2.178
Leiomyosarcoma metastases to the spine. Case series and review of the literature.
M. Elhammady (2007)
A novel in vitro three-dimensional retinoblastoma model for evaluating chemotherapeutic drugs
Moutushy Mitra (2012)
10.1038/nrm2236
The third dimension bridges the gap between cell culture and live tissue
F. Pampaloni (2007)
10.1016/j.ymeth.2010.01.001
Approaches toward super-resolution fluorescence imaging of mitochondrial proteins using PALM.
T. Brown (2010)
10.1126/SCIENCE.2451290
Cell and environment interactions in tumor microregions: the multicell spheroid model.
R. M. Sutherland (1988)
10.2174/138161209788453275
III. Angiogenesis: complexity of tumor vasculature and microenvironment.
M. Furuya (2009)
10.1054/bjoc.2001.1967
Prostate epithelial cell lines form spheroids with evidence of glandular differentiation in three-dimensional Matrigel cultures
S. Lang (2001)
10.1073/PNAS.89.19.9064
Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells.
O. W. Petersen (1992)
10.1002/ijc.26027
Do all roads lead to Rome? Routes to metastasis development
J. Sleeman (2011)
10.1111/j.1582-4934.2009.00810.x
Immune cells and angiogenesis
D. Ribatti (2009)
10.1186/1471-2407-10-299
Different significance between intratumoral and peritumoral lymphatic vessel density in gastric cancer: a retrospective study of 123 cases
X. Wang (2009)
10.1038/nrclinonc.2012.120
Cancer prevention by targeting angiogenesis
A. Albini (2012)
10.1177/1087057104265040
The Use of 3-D Cultures for High-Throughput Screening: The Multicellular Spheroid Model
L. Kunz-Schughart (2004)
10.1016/J.YEXCR.2005.11.015
Antiangiogenesis in cancer therapy--endostatin and its mechanisms of action.
J. Folkman (2006)



This paper is referenced by
10.3390/ijms20236017
Pre-Clinical Drug Testing in 2D and 3D Human In Vitro Models of Glioblastoma Incorporating Non-Neoplastic Astrocytes: Tunneling Nano Tubules and Mitochondrial Transfer Modulates Cell Behavior and Therapeutic Respons
Prospero Civita (2019)
10.1089/ADT.2010.0805.LR
Literature Search and Review
D. Auld (2013)
10.7150/jca.7813
Novel Phenotypic Fluorescent Three-Dimensional Co-Culture Platforms for Recapitulating Tumor in vivo Progression and for Personalized Therapy
Changge Fang (2013)
Blood flow in the myometrium of women with or without adenomyosis by three-dimensional power Doppler sonography
Tze-Sing Huang (2014)
10.1093/intbio/zyz012
Long-term fluorescence hyperspectral imaging of on-chip treated co-culture tumour spheroids to follow clonal evolution.
A. St-Georges-Robillard (2019)
10.1007/s00018-014-1738-5
Microscale screening systems for 3D cellular microenvironments: platforms, advances, and challenges
Sara I. Montanez-Sauri (2014)
10.4155/fmc.14.131
The use of high-throughput screening in identifying chemotherapeutic agents for gastric cancer.
H. Flotow (2014)
10.1111/jcmm.12300
Oestrogen-induced angiogenesis promotes adenomyosis by activating the Slug-VEGF axis in endometrial epithelial cells
T. Huang (2014)
10.6084/m9.figshare.2075422.v1
Book chapter: Exploring Subcellular Organization and Function with Quantitative Fluorescence Microscopy
Mahboubi Hicham (2016)
10.1080/17460441.2020.1756769
High-throughput screening in multicellular spheroids for target discovery in the tumor microenvironment
Blaise Calpe (2020)
10.1016/j.jbiotec.2015.01.002
In vitro co-culture model of medulloblastoma and human neural stem cells for drug delivery assessment.
D. P. Ivanov (2015)
10.1039/c4lc00866a
A quantitative microfluidic angiogenesis screen for studying anti-angiogenic therapeutic drugs.
C. Kim (2015)
10.1002/CITE.201400019
High Throughput Technology: Exemplary Highlights of Advanced Technical Tools
Sven Titlbach (2014)
Exploring Subcellular Organization and Function with Quantitative Fluorescence Microscopy
M. Kodiha (2014)
10.1126/scitranslmed.3010564
An implantable microdevice to perform high-throughput in vivo drug sensitivity testing in tumors
O. Jonas (2015)
Assessment of drug-loaded nanoparticles in a 3D in vitro brain tumour model
D. Ivanov (2015)
10.1016/j.copbio.2015.05.002
Microfluidic 3D cell culture: from tools to tissue models.
V. van Duinen (2015)
10.1371/journal.pone.0102678
Identifying and Quantifying Heterogeneity in High Content Analysis: Application of Heterogeneity Indices to Drug Discovery
A. Gough (2014)
10.37696/nkmj.679069
Üç Boyutlu Hücre Kültürü Sistemlerine Güncel Yaklaşımlar
E. Polat (2020)
Semantic Scholar Logo Some data provided by SemanticScholar